You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Liver conditions
  5. Alcohol-use disorders

Rifaximin for preventing episodes of overt hepatic encephalopathy

  • Technology appraisal guidance
  • Reference number: TA337
  • Published:  25 March 2015
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

Hepatic encephalopathy (maintenance treatment) - rifaximin: response to consultee and commentator comments on the draft scope and provisional matrix

Hepatic encephalopathy (maintenance treatment) - rifaximin: response to consultee and commentator comments on the draft scope and provisional matrix Hepatic encephalopathy (maintenance treatment) - rifaximin: response to consultee and commentator comments on the draft scope and provisional matrix
17 December 2012
(367.66 Kb 47 sec)

Adobe Acrobat reader required.

  Adobe Acrobat reader required.

This page was last updated: 13 December 2012

Back to top